Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.5850
0.00 (0.00%)
Feb 19, 2026, 3:59 PM AEST
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 169.17 million as of February 18, 2026. Its market cap has increased by 65.82% in one year.
Market Cap
169.17M
Enterprise Value
169.26M
Revenue
7.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.59
Market Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 169.17M, an increase of 723.33%. That is a compound annual growth rate of 23.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 169.17M | -10.00% |
| Dec 31, 2025 | 187.97M | 67.15% |
| Dec 31, 2024 | 112.46M | 3.19% |
| Dec 29, 2023 | 108.98M | -7.28% |
| Dec 30, 2022 | 117.53M | -34.34% |
| Dec 31, 2021 | 179.00M | -2.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 297.20M |
| Orthocell | 249.60M |
| Botanix Pharmaceuticals | 221.64M |
| Starpharma Holdings | 209.96M |
| Tetratherix | 183.77M |
| Actinogen Medical | 145.40M |
| Paradigm Biopharmaceuticals | 132.30M |
| Arovella Therapeutics | 112.08M |